These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 33027)
1. Biotransformation of prochiral 2-phenyl-1,3-di(4-pyridyl)-2-propanol to a chiral N-oxide metabolite. Schwartz MA; Williams TH; Kolis SJ; Postma E; Sasso GJ Drug Metab Dispos; 1978; 6(6):647-53. PubMed ID: 33027 [TBL] [Abstract][Full Text] [Related]
2. Doxylamine metabolism in rat and monkey. Ganes DA; Hindmarsh KW; Midha KK Xenobiotica; 1986 Sep; 16(9):781-94. PubMed ID: 3765658 [TBL] [Abstract][Full Text] [Related]
3. Species-specific, P450- and sulfotransferase-mediated novel ring contraction of a naphthyridine-N-oxide compound in cynomolgus monkey. Daniels JS; Espina R; Cao K; Yuan H; Lin J; Diamond S; Johnson B; Rodgers J; Prakash S; Unger S; Christ D; Miwa G; Gan LS; Mutlib A Chem Res Toxicol; 2007 Nov; 20(11):1709-17. PubMed ID: 17939741 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolites. Lundström J; Högberg T; Gosztonyi T; de Paulis T Arzneimittelforschung; 1981; 31(3):486-94. PubMed ID: 6452883 [TBL] [Abstract][Full Text] [Related]
5. Species differential stereoselective oxidation of a methylsulfide metabolite of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor dual agonist. Karanam BV; Welch CJ; Reddy VG; Chilenski J; Biba M; Vincent S Drug Metab Dispos; 2004 Oct; 32(10):1061-8. PubMed ID: 15229170 [TBL] [Abstract][Full Text] [Related]
6. Species variability in the stereoselective N-oxidation of pargyline. Hadley MR; Svajdlenka E; Damani LA; Oldham HG; Tribe J; Camilleri P; Hutt AJ Chirality; 1994; 6(2):91-7. PubMed ID: 8204418 [TBL] [Abstract][Full Text] [Related]
7. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans. Rodrigues AD; Ferrero JL; Amann MT; Rotert GA; Cepa SP; Surber BW; Machinist JM; Tich NR; Sullivan JP; Garvey DS Drug Metab Dispos; 1994; 22(5):788-98. PubMed ID: 7530622 [TBL] [Abstract][Full Text] [Related]
8. Reductive isoxazole ring opening of the anticoagulant razaxaban is the major metabolic clearance pathway in rats and dogs. Zhang D; Raghavan N; Chen SY; Zhang H; Quan M; Lecureux L; Patrone LM; Lam PY; Bonacorsi SJ; Knabb RM; Skiles GL; He K Drug Metab Dispos; 2008 Feb; 36(2):303-15. PubMed ID: 17984286 [TBL] [Abstract][Full Text] [Related]
9. Enzymatic reduction of xenobiotic alpha,beta-unsaturated ketones: formation of allyl alcohol metabolites from shogaol and dehydroparadol. Surh YJ; Lee SS Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):53-61. PubMed ID: 8042009 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of metyrapone. III. Formation of an alpha-pyridone metabolite by rat hepatic soluble enzymes. Damani LA; Crooks PA; Cowan DA Drug Metab Dispos; 1981; 9(3):270-3. PubMed ID: 6113939 [TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of amphetamine: an apparent enantiomeric interaction. Gal J; Wright J; Cho AK Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):525-40. PubMed ID: 996364 [TBL] [Abstract][Full Text] [Related]
12. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy. Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078 [TBL] [Abstract][Full Text] [Related]
13. N-deethylation and N-oxidation of etamiphylline: identification of etamiphylline-N-oxide in greyhound urine by high performance liquid chromatography-mass spectrometry. Dumasia MC; Teale P J Pharm Biomed Anal; 2005 Jan; 36(5):1085-91. PubMed ID: 15620536 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions. Kedderis GL; Argenbright LS; Walsh JS; Smith JL; Stearns RA; Arison BA; Miwa GT Drug Metab Dispos; 1989; 17(6):606-11. PubMed ID: 2575495 [TBL] [Abstract][Full Text] [Related]
15. Metabolites of [(14)C]-5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3, 6-tetrahydropyridine in mice, rats, dogs, and humans. Christensen EB; Andersen JB; Pedersen H; Jensen KG; Dalgaard L Drug Metab Dispos; 1999 Nov; 27(11):1341-9. PubMed ID: 10534320 [TBL] [Abstract][Full Text] [Related]
16. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid. Wang YP; Yan J; Fu PP; Chou MW Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625 [TBL] [Abstract][Full Text] [Related]
17. Enantiomeric aspects of the metabolism of mianserin in rats. Heinig R; Delbressine LP; Kaspersen FM; Blaschke G Arzneimittelforschung; 1993 Jul; 43(7):709-15. PubMed ID: 8369000 [TBL] [Abstract][Full Text] [Related]
18. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
19. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs. Andersson SH; Lindgren A; Postlind H Drug Metab Dispos; 1998 Jun; 26(6):528-35. PubMed ID: 9616187 [TBL] [Abstract][Full Text] [Related]
20. Stereospecific in vivo N-methylation of nicotine in the guinea pig. Cundy KC; Sato M; Crooks PA Drug Metab Dispos; 1985; 13(2):175-85. PubMed ID: 2859165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]